首页> 外文期刊>Applied cancer research. >In vivo antitumor potential of extracts from different parts of Bauhinia variegata linn. Against b16f10 melanoma tumour model in c57bl/6 mice
【24h】

In vivo antitumor potential of extracts from different parts of Bauhinia variegata linn. Against b16f10 melanoma tumour model in c57bl/6 mice

机译:紫荆花不同部位提取物的体内抗肿瘤潜力。针对c57bl / 6小鼠中的b16f10黑色素瘤肿瘤模型

获取原文
           

摘要

Background Melanoma is a metastatic type of skin cancer that is difficult to treat and the majority of efforts are directed to the design of new drugs. Medicinal Plants have been the primary source of medicines since life on earth; more than 50% of existing cancer treatments is derived from plants. Bauhinia variegata is well-known medicinal plant used from the ancient era to till date for their medicinal values. Scientific literatures have not documented any evidence of the antitumour potential of Bauhinia variegata against B16F10 melanoma tumor model in C57BL mice. The present investigation was undertaken to explore the antitumour activity of Leaf, stem bark and flower extract of Bauhinia variegata against B16F10 melanoma tumour model in C57BL mice. Methods Hydro-methanolic extract prepared from the leaf, stem bark and flower of Bauhinia variegata were assessed for their antitumor activity. The extracts at doses of 500 and 750?mg/kg b.wt. were given orally along with cyclophosphamide (chemotherapeutic drug) for 40?days for exploring antitumor activity against melanoma tumor (B16F10) in C57BL mice. Inhibition of tumor growth, increase in survival time of animal with treatment, histopathological studies and antioxidant parameter were determined. Results The Present investigation showed significant effect of the B. variegata L. in preventing melanoma tumor by B16F10 cell line in C57BL/6 mice. As compared with the tumour control group, the remarkable results especially in the group which received B. variegata extract and cyclophosphamide together were obtained for all of the measured parameters. Dose dependent response was observed in tumor volume, inhibition rate, life span time and antioxidant parameter of extracts. Combination treatment of cyclophosphamide and B. variegata extracts showed more pronounced effect. Conclusions These findings suggest that B. variegata hydromethanolic extract may contain bioactive compounds of potential therapeutic significance which are relatively safe from toxic effects, and can compromise the medicinal use of this plant in folk medicine.
机译:背景技术黑色素瘤是一种难以治疗的转移性皮肤癌,大部分工作都针对新药的设计。自从地球上的生命以来,药用植物一直是药物的主要来源。现有癌症治疗方法的50%以上来自植物。紫荆花(Bauhinia variegata)是一种著名的药用植物,自古以来一直以其药用价值而使用。科学文献尚未证明紫荆花对C57BL小鼠的B16F10黑色素瘤模型具有抗肿瘤潜力的任何证据。本研究旨在探讨紫荆花叶,茎皮和花提取物对C57BL小鼠B16F10黑色素瘤模型的抗肿瘤活性。方法对紫荆花的叶,茎,皮和花中提取的乙醇提取物进行抗肿瘤活性的评价。提取物的剂量为500和750?mg / kgb.wt。与环磷酰胺(化疗药物)一起口服40天,以研究C57BL小鼠对黑色素瘤(B16F10)的抗肿瘤活性。确定了抑制肿瘤生长,通过治疗增加动物的存活时间,组织病理学研究和抗氧化剂参数。结果本研究表明,通过C16BL / 6小鼠的B16F10细胞系,杂色芽胞杆菌在预防黑色素瘤中具有显著作用。与肿瘤对照组相比,对于所有测量参数,均获得了显着效果,尤其是在同时接受了杂色芽孢杆菌提取物和环磷酰胺的组中。在提取物的肿瘤体积,抑制率,寿命和抗氧化剂方面观察到剂量依赖性反应。环磷酰胺和杂色芽孢杆菌提取物的联合处理显示出更明显的效果。结论这些发现表明,杂色曲霉氢甲醇提取物可能含有具有潜在治疗意义的生物活性化合物,相对于毒性作用而言是相对安全的,并且可能损害该植物在民间医学中的医学用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号